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Summary
The related small GTPases Ras and Rap1 are impor-
tant for signaling synaptic AMPA receptor (-R) traf-
ficking during long-term potentiation (LTP) and long-
term depression (LTD), respectively. Rap2, which
shares 60% identity to Rap1, is present at excitatory
synapses, but its functional role is unknown. Here,
we report that Rap2 activity, stimulated by NR2A-con-
taining NMDA-R activation, depresses AMPA-R-medi-
ated synaptic transmission via activation of JNK
rather than Erk1/2 or p38 MAPK. Moreover, Rap2
controls synaptic removal of AMPA-Rs with long cyto-
plasmic termini during depotentiation. Thus, Rap2-JNK
pathway, which opposes the action of the NR2A-con-
taining NMDA-R-stimulated Ras-ERK1/2 signaling and
complements the NR2B-containing NMDA-R-stimu-
lated Rap1-p38 MAPK signaling, channels the specific
signaling for depotentiating central synapses.
Introduction
The sustained interest in synaptic plasticity stems from
the belief that synaptic plasticity underlies key aspects
of cognitive function such as neural development,
adaptation, and learning and memory. In current mod-
els, brief periods of repetitive synaptic activity lead to*Correspondence: jjzhu@virginia.edu
7 These authors contributed equally to this work.
8 Present address: Department of Pharmacology, Georgetown Uni-
versity School of Medicine, Washington, DC 20057.long-lasting changes in synaptic transmission; NMDA-
sensitive glutamate receptor (NMDA-R) opening, rise in
postsynaptic calcium concentration, activation of in-
tracellular signaling pathways, and synaptic delivery
and removal of AMPA-sensitive glutamate receptors
(AMPA-Rs) are critical events underlying different forms
of synaptic plasticity (Bredt and Nicoll, 2003; Malinow
and Malenka, 2002; Sheng and Kim, 2002; Thomas and
Huganir, 2004). There is now compelling evidence that
AMPA-Rs with long cytoplasmic tails (e.g., GluR1 or
GluR2L) are normally delivered to synapses during ac-
tivity-induced synaptic enhancement. On the other
hand, AMPA-Rs with only short cytoplasmic tails (i.e.,
GluR2/3) cycle continuously from nonsynaptic to syn-
aptic sites and replace synaptic receptors without
changing the synaptic efficacy; their number at syn-
apses can be reduced after activity-induced synaptic
depression. Our recent study has demonstrated that
small GTPase Ras, dependent on extracellular-regu-
lated kinase 1 and 2 (Erk1/2), controls synaptic delivery
of GluR1- and GluR2L-containing AMPA-Rs during
long-term potentiation (LTP), whereas small GTPase
Rap1, dependent on 38 kDa mitogen-activated pro-
tein kinase (p38 MAPK), controls synaptic removal of
GluR2/3 during long-term depression (LTD) (Zhu et al.,
2002). However, it is still unclear what signaling path-
way controls synaptic removal of GluR1- and GluR2L-
containing AMPA-Rs.
The small GTPase Rap2 is a member of the Ras
GTPase family that exhibits 60% identity to Rap1 (Takai
et al., 2001). Although Rap2 has been cloned for more
than 15 years (Pizon et al., 1988), its functional role re-
mains elusive. One possibility is that, like Rap1 and
Ras, Rap2 may function in MAP kinase signaling, since
a recent report suggests that Rap2 activity stimulates
c-Jun NH2-terminal kinase (JNK) activity in nonneu-
ronal cells (Machida et al., 2004). As with Erk1/2 and
p38 MAPK, JNK is another major MAPK that controls
essential cellular processes (Weston and Davis, 2002).
However, several pivotal questions, such as whether
Rap2-JNK constitutes a functional signaling pathway,
what controls Rap2-JNK activity, and which cellular
processes depend on Rap2-JNK signaling, remain un-
known, in neuronal and nonneuronal cells.
Rap2 and JNK, as well as their regulators, are ex-
pressed at excitatory synapses (Husi et al., 2000; Pak
et al., 2001; Peng et al., 2004). In this study, we have
investigated the role of Rap2 in activity-dependent syn-
aptic plasticity. Using several mutants that permit dis-
section of the role of Rap2 signaling, we identified a
functional Rap2 signaling pathway in hippocampal CA1
neurons. Rap2-JNK signaling pathway receives its in-
puts from synaptic and NMDA-R activity: synaptic ac-
tivity and activation of NR2A-containing NMDA-Rs acti-
vate Rap2, which stimulates JNK activity. Rap2-JNK
signaling pathway sends its outputs to AMPA-Rs:
Rap2-JNK activity mediates synaptic removal of GluR1-
and GluR2L-containing AMPA-Rs and is essential for
depotentiation. It is notable that Rap2 activity (depo-
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To determine if Rap2 is present in hippocampal tissue, N
we prepared extracts from whole hippocampus and r
also a microdissected CA1 region of hippocampus. G
Western blots on these extracts show bands corre- h
sponding to Rap2 indicating that these proteins are R
present in hippocampal CA1 cells (Figure 1A; see also 3
Husi et al., 2000). To examine possible postsynap- s
tic functions of these molecules, we acutely overex- l
pressed wild-type Rap2 or their mutants in hippocam- i
pal CA1 pyramidal neurons. These constructs were r
tagged with GFP, allowing unambiguous identification u
of expressing cells. Approximately 14 hr after infection, n
the expression level of Rap2-GFP ranged from two to a
eight times the endogenous Rap2 level (Figure 1A). In m
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mFigure 1. Expression of Rap2 in Hippocampal CA1 Cells
a
(A) (Left) Expression of endogenous and recombinant Rap2 pro-
steins in hippocampal CA1 regions, whole hippocampi, and hippo-
campal CA1 regions expressing Rap2-GFP. (Right) Relative amounts
of endogenous Rap2 in whole hippocampi (n = 11; p < 0.05) or m
recombinant Rap2 in hippocampal CA1 regions expressing Rap2- R
GFP (n = 11; p < 0.005). The relative values and standard errors G
were normalized to average amounts of endogenous Rap2 from t
hippocampal CA1 regions.
s(B) Two-photon images of GFP fluorescence indicate that Rap2-
dGFP proteins are present in the dendrites and spines of CA1 py-
rramidal neurons. The dendritic spines are demarcated by RFP fluo-
rescence. G
(C) (Upper) Evoked AMPA-R-mediated (−60 mV) and NMDA-R- n
mediated (+40 mV) responses recorded from nonexpressing (Ctrl) s
and Rap2(ca)-GFP-expressing cells. Rap2-GFP mutants were ex-
apressed in cultured slices in normal culture media for w14 hr.
T(Lower left) AMPA responses in cells expressing Rap2(ca)-GFP (n =
a14; p < 0.01) or Rap2(dd)-GFP (n = 16; p = 0.96) relative to neighbor-
ing nonexpressing control cells. (Lower right) NMDA responses in m
cells expressing Rap2-GFP(ca) (n = 14; p = 0.98) or Rap2(dd)-GFP
(n = 16; p = 0.57) relative to neighboring nonexpressing control i
cells. *p < 0.05. See Supplemental Data for the values. i
tted and infiltrated in dendritic spines, the sites of ex-
itatory synapses (Figure 1B). To determine whether
ap2 affects synaptic function, electrophysiological re-
ordings were obtained simultaneously from nearby ex-
ressing and nonexpressing neurons. Afferent fibers
ere stimulated, and excitatory postsynaptic currents
ere recorded. Neurons expressing a constitutively
ctive mutant Rap2(V12), Rap2(ca)-GFP, showed w50%
epressed AMPA-R-mediated responses. There was no
ignificant difference in NMDA-R-mediated responses
etween Rap2(ca)-GFP-expressing and nonexpressing
eurons (Figure 1C), consistent with the previous find-
ng that synaptic NMDA-Rs and AMPA-Rs are differenti-
lly regulated (Rao and Craig, 1997), and suggesting
hat the Rap2(ca)-GFP-stimulated depression was not
ediated by nonspecific mechanisms. As an addi-
ional control, neurons expressing an inactive mutant
ap2(S39), Rap2(dd)-GFP, showed no change in trans-
ission (Figure 1C). These results indicate that Rap2
ctivity selectively downmodulates AMPA-R-mediated
ynaptic transmission.
To test if endogenous Rap2 activity depresses trans-
ission, we expressed a dominant-negative mutant
ap2(N17), Rap2(dn)-GFP. Neurons expressing Rap2(dn)-
FP showed potentiated AMPA responses compared
o nearby nonexpressing neurons (Figures 2A and 2B),
uggesting that blocking endogenous Rap2 activity
isinhibited synaptic transmission. Furthermore, neu-
ons expressing the wild-type form of Rap2, Rap2(wt)-
FP, showed depressed AMPA responses compared to
earby nonexpressing neurons (Figures 2A and 2B),
uggesting that increasing Rap2 activity enhanced syn-
ptic depression in Rap2(wt)-GFP-expressing neurons.
hese results support the view that endogenous Rap2
ctivity contributes to a tonic depression of trans-
ission.
To determine whether the endogenous Rap2 signal-
ng is stimulated by synaptic and NMDA-R activity, we
ncluded 12 mM MgCl2, which depresses synaptic
ransmission (Zhu et al., 2000), or APV, a pharmacologi-
al blocker of NMDA-Rs, in culture media during ex-
ression of Rap2(dn)-GFP or Rap2(wt)-GFP. High Mg2+
nd APV blocked the effects of Rap2(dn)-GFP and
ap2(wt)-GFP on AMPA synaptic transmission (Figure
B), indicating that Rap2-mediated effects required
ynaptic activity and activation of NMDA-Rs. As a con-
rol, we found that the depression of Rap2(ca)-GFP on
MPA-R-mediated transmission was not blocked by
igh Mg2+ (Figure 3E). To confirm that activation of
MDA-Rs stimulates Rap2 activity, we measured di-
ectly the active form of Rap2 (or GTP bound Rap2) by a
ST pull-down assay. Application of NMDA to cultured
ippocampal neurons caused a transient increase in
ap2-GTP levels that returned to baseline withinw15–
0 min (Figure 2C). To further confirm that spontaneous
ynaptic activity activates Rap2, we measured the
evels of Rap2-GTP in slices cultured in media contain-
ng either high Mg2+ or APV. Both high Mg2+ and APV
educed the active form of Rap2-GTP in CA1 cells (Fig-
re 2D). Collectively, these results indicate that sponta-
eous synaptic activity activates NMDA-Rs that in turn
ctivate Rap2, producing a tonic depression of trans-
ission.
Recent studies have shown that NR2A- and NR2B-
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907Figure 2. NR2A-Containing NMDA-R-Stimulated Rap2 Activity De-
presses Synaptic Transmission
(A) Evoked AMPA-R- and NMDA-R-mediated responses recorded
from nonexpressing (Ctrl) and Rap2(dn)-GFP cells or Rap2(wt)-
GFP-expressing cells cultured in normal or 12 mM Mg2+ media.
(B) (Left) AMPA responses in Rap2(dn)-GFP- and Rap(wt)-GFP-
expressing cells cultured in normal media [n = 16, p < 0.01 for
Rap2(dn)-GFP; n = 16, p < 0.05 for Rap2(wt)-GFP], media with 12
mM Mg2+ [n = 16, p = 0.92 for Rap2(dn)-GFP; n = 16, p = 0.84 for
Rap2(wt)-GFP], or media with 100 M DL-APV [n = 16, p = 0.50 for
Rap2(dn)-GFP; n = 16, p = 0.94 for Rap2(wt)-GFP]. (Right) NMDA
responses in Rap2(dn)-GFP- and Rap2(wt)-GFP-expressing cells
cultured in normal media [n = 16, p = 0.66 for Rap2(dn)-GFP; n =
16, p = 0.76 for Rap2(wt)-GFP], media with 12 mM Mg2+ [n = 16,
p = 0.54 for Rap2(dn)-GFP; n = 16, p = 0.50 for Rap2(wt)-GFP], or
media with 100 M DL-APV [n = 16, p = 0.54 for Rap2(dn)-GFP; n =
16, p = 0.41 for Rap2(wt)-GFP]. AMPA-R- and NMDA-R-mediated
current amplitude and standard errors were normalized to average
values from control cells. *p < 0.05 (Wilcoxon test).
(C) (Left) Levels of GTP bound Rap2 in cultured hippocampal neu-
rons at 3, 7, 15, and 30 min following treatment with 60 M NMDA.
Each lane was loaded with affinity precipitate from 200 g total
protein. (Right plot) Levels of active Rap2-GTP against time. Rela-
tive amounts of Rap2-GTP at 3 min (n = 4; paired Student’s t test;
p < 0.05), 7 min (n = 4; paired Student’s t test; p < 0.01), 15 min (n =
4; paired Student’s t test; p = 0.23), and 30 min (n = 4; paired Stu-
dent’s t test; p = 0.09) after NMDA application.
(D) (Left) Relative levels of GTP bound Rap2 and total Rap2 in hip-
pocampal CA1 regions prepared from slices cultured in normal me-
dia (Ctrl) or media containing 12 mM Mg2+ or 100 M DL-APV. For
each set of hippocampal CA1 cell lysate, 35 g protein was used
to purify and blot GTP bound Rap2, and 7.5 g protein was used
to directly blot total Rap2. (Right) Relative amounts of Rap2-GTP
in hippocampal CA1 regions prepared from slices cultured in 12
mM Mg2+ (n = 11; p < 0.01) or 100 M DL-APV (n = 11; p < 0.005).
Relative amounts of total Rap2 in hippocampal CA1 regions pre-
pared from slices cultured in 12 mM Mg2+ (n = 11; p = 0.33) or 100
M DL-APV (n = 11; p = 0.89). The relative values and standard
errors were normalized to average amounts of Rap2-GTP or total
Rap2 from control untreated cells.binding partners of Rap2-GTP by affinity chromatogra-
(E) Evoked AMPA-R- and NMDA-R-mediated responses recorded
from nonexpressing (Ctrl) and Rap2(dn)-GFP cells or Rap1(dn)-
GFP-expressing cells cultured in media containing 0.4 M Ro25-
6981 or 0.4 M NVP-AAM077.
(F) (Left) AMPA responses in Rap2(dn)-GFP-expressing cells cul-
tured in media with 0.4 M Ro25-6981 (n = 12; p < 0.05) or media
with 0.4 M NVP-AAM077 (n = 20; p = 0.75), in Rap1(dn)-GFP-
expressing cells cultured in media with 0.4 M Ro25-6981 (n = 16;
p = 0.78) or media with 0.4 M NVP-AAM077 (n = 14; p < 0.05), or
in Ras(dn)-GFP-expressing cells cultured in media with 0.4 M
Ro25-6981 (n = 14; p < 0.01) or media with 0.4 M NVP-AAM077
(n = 16; p = 0.61). (Right) NMDA responses in Rap2(dn)-GFP-
expressing cells cultured in media with 0.4 M Ro25-6981 (n = 12;
p = 0.88) or media with 0.4 M NVP-AAM077 (n = 20; p = 0.33), in
Rap1(dn)-GFP-expressing cells cultured in media with 0.4 M
Ro25-6981 (n = 16; p = 0.30) or media with 0.4 M NVP-AAM077
(n = 14; p = 0.25), or in Ras(dn)-GFP-expressing cells cultured in
media with 0.4 M Ro25-6981 (n = 14; p = 0.30) or media with 0.4
M NVP-AAM077 (n = 16; p = 0.22). AMPA-R- and NMDA-R-medi-
ated current amplitude and standard errors were normalized to
average values from control cells. *p < 0.05 (Wilcoxon test). See
Supplemental Data for the values.containing NMDA-Rs differ significantly in biophysical
properties and may thus be designed for controlling de-
potentiation/LTP and LTD, respectively (Erreger et al.,
2005; Liu et al., 2004; Massey et al., 2004). We wished
to know whether NR2A- or NR2B-containing NMDA-Rs
or both control Rap2 activity, and we therefore exam-
ined the effects of two selective blockers for NR2A- and
NR2B-containing NMDA-Rs on the Rap2(dn)-GFP-stim-
ulated synaptic potentiation. We included Ro25-6981,
which selectively blocks NR2B-containing NMDA-Rs
and LTD (Liu et al., 2004; Massey et al., 2004), or NVP-
AAM077, which selectively blocks NR2A-containing
NMDA-Rs and depotentiation/LTP (Liu et al., 2004;
Massey et al., 2004), in culture media during expression
of Rap2(dn)-GFP. We found that NVP-AAM077, but not
Ro25-6981, blocked the potentiation stimulated by
Rap2(dn)-GFP (Figures 2E and 2F). These results indi-
cate that stimulation of Rap2 signaling requires activa-
tion of NR2A-containing NMDA-Rs, but not NR2B-con-
taining NMDA-Rs. As controls, we also examined
effects of these two NMDA-R blockers on Rap1 and
Ras activities, which mediate LTD and LTP, respectively
(Zhu et al., 2002). We found that Ro25-6981, but not
NVP-AAM077, blocked the Rap1(dn)-GFP-stimulated
potentiation, whereas NVP-AAM077, but not Ro25-
6981, blocked the Ras(dn)-GFP-stimulated synaptic
depression (Figures 2E and 2F). These results indicate
that stimulation of Rap1 signaling requires activation of
NR2B-containing NMDA-Rs, whereas stimulation of
Ras signaling requires activation of NR2A-containing
NMDA-Rs. Collectively, these results indicate that dif-
ferent subtypes of NMDA-Rs are functionally coupled
to different Ras family GTPases (i.e., Ras, Rap1, and
Rap2) and that activations of NR2A- and NR2B-con-
taining NMDA-Rs stimulate Rap2 and Rap1 activity,
respectively.
Rap2 Activity Stimulates JNK Signaling
To identify potential effectors of Rap2 that might be in-
volved in signaling synaptic depression, we purified
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Figure 3. Rap2 Signals Synaptic Depression via Activation of JNK s
(A) A prominent band specifically associated with GST-Rap2(ca), J
indicated by the arrow, was excised and subjected to tandem mass t
spectrometry for protein identification, yielding 21 peptides match- e
ing to Traf2- and NCK-interacting kinase (TNIK) and 1 peptide b
matching to MINK2 (a TNIK-related kinase).
r(B) Evoked AMPA-R- and NMDA-R-mediated responses recorded
cfrom nonexpressing (Ctrl) and TNIK(dn)-GFP-expressing cells cul-
Stured in normal media or media containing 12 mM Mg2+.
(C) (Left) AMPA responses in TNIK(dn)-GFP-expressing cells cul- 4
tured in normal media (n = 15; p < 0.01) or media containing 12 r
mM Mg2+ (n = 16; p = 0.61), or TNIK(dn)-GFP and Rap2(ca)-RFP- i
coexpressing cells cultured in normal media (n = 16; p = 0.31).
i(Right) NMDA responses in Rap2(ca)-GFP-expressing cells cul-
rtured in normal media (n = 15; p = 0.82) or media containing 12
umM Mg2+ (n = 16; p = 0.61), or TNIK(dn)-GFP and Rap2(ca)-RFP-
coexpressing cells cultured in normal media (n = 16; p = 0.76). n
AMPA-R- and NMDA-R-mediated current amplitude and standard O
errors were normalized to average values from control cells. R
(D) Evoked AMPA-R- and NMDA-R-mediated responses recorded t
from nonexpressing (Ctrl) and Rap2(ca)-GFP-expressing cells cul-
dtured in media containing 5 M SP600125, 12 mM Mg2+, or FK506.
i(E) (Left) AMPA responses in Rap2(ca)-GFP-expressing cells cul-
itured in media containing 5 M SP600125 (n = 14; p = 0.88), 5 M
SP600125 for 12 hr followed by normal media for 4–6 hr (n = 14; p < i
0.005), 2 M SB203580 (n = 16; p < 0.005), 25 M PD98059 (n = 14; (
p < 0.005), 12 mM Mg2+ (n = 18; p < 0.005), 25 M FK-506 (n = 14; R
p = 0.88), or 150 M CsA (n = 16; p = 0.38). (Right) NMDA responses c
in Rap2(ca)-GFP-expressing cells cultured in media containing 5
qM SP600125 (n = 14; p = 0.33), 5 M SP600125 for 12 hr followed
tby normal media for 4–6 hr (n = 14; p = 0.73), 2 M SB203580 (n =
16; p = 0.35), 25 M PD98059 (n = 14; p = 0.47), 12 mM Mg2+ (n = 18;
p = 0.68), 25 M FK-506 (n = 14; p = 0.93), or 150 M CsA (n = 16; p
p = 0.30). AMPA-R- and NMDA-R-mediated current amplitude and c
standard errors were normalized to average values from control Z
cells. *p < 0.05 (Wilcoxon test). See Supplemental Data for the o
values.
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p
phy from rat brain extracts (Figure 3A). One prominent p
150 kDa band was isolated that bound specifically to s
GST-Rap2(ca), but not GST-Rap1(ca) or GST alone (Fig- p
Rure 3A). Tandem mass spectrometry of the band yielded1 peptides matching to Traf2- and NCK-interacting ki-
ase (TNIK) and 1 peptide matching to MINK2 (a TNIK-
elated kinase). These highly related kinases are mem-
ers of the STE20 family of protein kinases that initiate
AP kinase cascades—TNIK and MINK2 have been
hown to specifically act upstream of the JNK pathway
Dan et al., 2001). To test whether TNIK is involved
n the Rap2-stimulated synaptic depression, we ex-
ressed a GFP-tagged dominant-negative form of TNIK
ontaining only the CNH domain, TNIK(dn)-GFP, alone
r with the RFP-tagged constitutively active Rap2(ca),
ap2(ca)-RFP. Neurons expressing TNIK(dn)-GFP had
nhanced AMPA responses in comparison to nearby
onexpressing neurons, while NMDA responses were
ot significantly changed (Figures 3B and 3C). In addi-
ion, including high Mg2+ in culture media blocked the
NIK(dn)-GFP-stimulated synaptic potentiation. These
esults suggested that synaptic activity stimulates en-
ogenous TNIK signaling that depresses synaptic
ransmission. Moreover, coexpressing TNIK(dn)-GFP
ith Rap2(ca)-RFP blocked the Rap2(ca)-stimulated
ynaptic depression in coexpressing neurons (Figure
C), suggesting that TNIK may be a downstream effec-
or of Rap2 in CA1 neurons.
Since TNIK specifically stimulates JNK signaling (Dan
t al., 2001), we wished to know whether the Rap2-
timulated synaptic depression might be mediated by
NK. To test this idea, we included SP600125, an inhibi-
or of JNK (Bennett et al., 2001), in culture media during
xpression of Rap2(ca)-GFP. We found that SP600125
locked the inhibitory effect of Rap2(ca)-GFP on AMPA
esponses (Figures 3D and 3E). Moreover, we initially
ultured hippocampal tissues in media containing
P600125 for 12 hr, then in normal media for another
–6 hr. We found that Rap2(ca)-GFP-expressing neu-
ons treated this way had depressed AMPA responses
n comparison to nonexpressing neurons (Figure 3E),
ndicating that the inhibitory effect of blocking JNK was
eversible. This result suggests that the Rap2-stim-
lated synaptic depression was unlikely mediated by
onspecific mechanisms (cf. McCarthy et al., 1995).
ur recent study has demonstrated that small GTPase
as, dependent on Erk1/2, controls synaptic potentia-
ion during LTP, whereas small GTPase Rap1, depen-
ent on p38 MAPK, controls synaptic depression dur-
ng LTD (Zhu et al., 2002). Neither SB203580, which
nhibits p38 MAPK (Lee et al., 1999), or PD98059, which
nhibits MEK (an upstream kinase of the ERK pathway)
Dudley et al., 1995), blocked the depressive effect of
ap2(ca)-GFP (Figures 3D and 3E). These results indi-
ate that the Rap2-stimulated synaptic depression re-
uires JNK activity, but not Erk1/2 or p38 MAPK ac-
ivity.
Previous studies have indicated that synaptic de-
ression requires phosphatase 2B (also known as
alcineurin) (Malleret et al., 2001; Mulkey et al., 1993;
huo et al., 1999). We found that the depressive effect
f Rap2(ca)-GFP was blocked by FK-506 or cyclosporin
(CsA; Figures 3D and 3E), inhibitors of protein phos-
hatase 2B (Winder and Sweatt, 2001), indicating that
hosphatase 2B is required for Rap2-JNK-mediated
ynaptic depression. However, it is unclear whether
hosphatase 2B relays or is merely required for the
ap2 effect.
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909To examine whether Rap2 signaling stimulates JNK
activity, we immunoblotted hippocampal slices ex-
pressing Rap2(ca)-GFP or Rap2(dn)-GFP. Levels of
phosphorylated (active) JNK increased in CA1 cells ex-
pressing Rap2(ca)-GFP and decreased in CA1 cells
expressing Rap2(dn)-GFP (Figure 4A). Phospho-JNK
levels were unchanged by Ras(ca)-GFP, Ras(dn)-GFP,
Rap1(ca)-GFP, or Rap1(dn)-GFP (Figure 4A). In addition,
phosphorylated Erk1/2 and p38 MAPK were unchanged
in CA1 cells expressing Rap2(ca)-GFP or Rap2(dn)-GFP
(Figures 4B and 4C). The above results indicate that
Rap2 acts through JNK to depress AMPA-R-mediated
synaptic transmission.
Rap2-JNK Activity Controls
Long-Term Depotentiation
We have recently shown that Rap1 controls LTD via ac-
tivation of p38 MAPK (Zhu et al., 2002). Since the de-
pressive effect of Rap2 requires JNK but not p38
MAPK, we speculated that Rap2-JNK signaling con-
trols depotentiation. To test this idea, we studied pair-
ing-induced depotentiation after first applying a LTP-
inducing pairing protocol in neurons expressing either
Rap2(dn)-GFP (to block endogenous Rap2 activity) or
Rap2(ca)-GFP (to occlude Rap2 activity). As with a pre-
vious report (Lee et al., 2000), we found that the pairingFigure 4. Rap2 Activity Stimulates JNK Sig-
naling
(A) Western blots of phospho-p46/54 JNK in
control hippocampal CA1 regions, hippo-
campal CA1 regions expressing Rap2(ca)-
GFP, and hippocampal CA1 regions express-
ing Rap2(dn)-GFP. Each lane was loaded
with the same amount of protein (40 g).
(Left histograms) Relative amounts of phos-
pho-p46/54 JNK in hippocampal CA1 re-
gions expressing Rap2(ca)-GFP (n = 17, p <
0.005 for phospho-p46 JNK; n = 17, p < 0.01
for phospho-p54 JNK) or Rap2(dn)-GFP (n =
17, p < 0.01 for phospho-p46 JNK; n = 17,
p < 0.001 for phospho-p54 JNK). Relative
amounts of total p46/54 JNK in hippocampal
CA1 regions expressing Rap2(ca)-GFP (n =
17, p = 0.60 for p46 JNK; n = 17, p = 0.49 for
p54 JNK) or Rap2(dn)-GFP (n = 17, p = 0.76
for p46 JNK; n = 17, p = 0.59 for p54 JNK).
(Middle histograms) Relative amounts of
phospho-p46/54 JNK in hippocampal CA1 regions expressing Ras(ca)-GFP (n = 19, p = 0.88 for phospho-p46 JNK; n = 19, p = 0.87 for
phospho-p54 JNK) or Ras(dn)-GFP (n = 19, p = 0.75 for phospho-p46 JNK; n = 19, p = 0.97 for phospho-p54 JNK). Relative amounts of total
p46/54 JNK in hippocampal CA1 regions expressing Ras(ca)-GFP (n = 19, p = 0.42 for p46 JNK; n = 19, p = 0.32 for p54 JNK) or Ras(dn)-GFP
(n = 19, p = 0.94 for p46 JNK; n = 19, p = 0.97 for p54 JNK). (Right histograms) Relative amounts of phospho-p46/54 JNK in hippocampal
CA1 regions expressing Rap1(ca)-GFP (n = 20, p = 0.48 for phospho-p46 JNK; n = 20, p = 0.77 for phospho-p54 JNK) or Rap1(dn)-GFP (n =
20, p = 0.26 for phospho-p46 JNK; n = 20, p = 0.63 for phospho-p54 JNK). Relative amounts of total p46/54 JNK in hippocampal CA1 regions
expressing Rap1(ca)-GFP (n = 20, p = 0.46 for p46 JNK; n = 20, p = 0.58 for p54 JNK) or Rap1(dn)-GFP (n = 20, p = 0.46 for p46 JNK; n = 20,
p = 0.60 for p54 JNK).
(B) (Left) Western blots of phospho-p42/44 MAPK in control hippocampal CA1 regions, hippocampal CA1 regions expressing Rap2(ca)-GFP,
and hippocampal CA1 regions expressing Rap2(dn)-GFP. Each lane was loaded with the same amount of protein (40 g). (Right) Relative
amounts of phospho-p42/44 MAPK in hippocampal CA1 regions expressing Rap2(ca)-GFP (n = 20, p = 0.72 for phospho-p42 MAPK; n = 20,
p = 0.63 for phospho-p44 MAPK) or Rap2(dn)-GFP (n = 20, p = 0.68 for phospho-p42 MAPK; n = 20, p = 0.50 for phospho-p44 MAPK).
Relative amounts of total p42/44 MAPK in hippocampal CA1 regions expressing Rap2(ca)-GFP (n = 20, p = 0.71 for p42 MAPK; n = 20, p =
0.25 for p44 MAPK) or Rap2(dn)-GFP (n = 20, p = 0.24 for p42 MAPK; n = 20, p = 0.42 for p44 MAPK).
(C) (Left) Western blots of phospho-p38 MAPK in control hippocampal CA1 regions, hippocampal CA1 regions expressing Rap2(ca)-GFP, and
hippocampal CA1 regions expressing Rap2(dn)-GFP. Each lane was loaded with the same amount of protein (40 g). (Right) Relative amounts
of phospho-p38 MAPK in hippocampal CA1 regions expressing Rap2(ca)-GFP (n = 20; p = 0.66) or Rap2(dn)-GFP (n = 20; p = 0.94). Relative
amounts of total p38 MAPK in hippocampal CA1 regions expressing Rap2(ca)-GFP (n = 20; p = 0.85) or Rap2(dn)-GFP (n = 20; p = 0.39). The
relative values and standard errors were normalized to average amounts of phospho-JNK, phospho-Erk1/2, phospho-p38 MAPK, total JNK,
total Erk1/2, or total p38 MAPK from control hippocampal CA1 regions. *p < 0.05 (Wilcoxon test). See Supplemental Data for the values.protocol using 300 pulses at 1 Hz at −45 mV, which is
optimal to induce LTD (Zhu et al., 2002), was also an
optimal protocol to induce depotentiation after LTP
(Figure 5). To determine whether Rap2 activity is neces-
sary and sufficient for depotentiation, we isolated de-
potentiation by including SB203580, the p38 MAPK in-
hibitor that blocks LTD (Zhu et al., 2002), in the bath
solution in all depotentiation experiments. In Rap2(dn)-
GFP-expressing neurons, basal synaptic responses
were initially potentiated compared to nearby control
nonexpressing neurons (see also Figures 2A and 2B),
suggesting a blockade of endogenous Rap2 activity.
LTP-inducing stimuli produced a lasting potentiation in
neurons expressing Rap2(dn)-GFP, but the subsequent
depotentiation protocol failed to revert potentiated
AMPA responses back to baseline (Figures 5A–5C). In
contrast, nearby nonexpressing neurons showed path-
way-specific LTP, followed by complete depotentiation
(Figures 5A–5C). These results indicate that blocking
Rap2 activity blocks depotentiation. In Rap2(ca)-GFP-
expressing neurons, basal synaptic responses were
initially smaller compared to nearby control nonex-
pressing neurons (see also Figure 1C), suggesting an
enhancement of Rap2 activity. LTP stimuli produced a
brief potentiation, but no sustained LTP and no depo-
tentiation were observed in these neurons (Figures 5D–
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Figure 5. Rap2 Activity Controls Long-Term Depotentiation d
w(A) Average AMPA-R-mediated synaptic responses obtained before
(−60 mV; thick trace) and after (−60 mV; thin trace) LTP-depotentia- s
tion-inducing pairing from a pair of Rap2(dn)-GFP-expressing and t
neighboring nonexpressing cells in LTP-depotentiation double p
paired (upper left) and control pathway (upper right). (Lower plot)
rSimultaneously evoked responses recorded from the cell pairs ex-
Rpressing or not expressing Rap2(dn)-GFP against time.
6(B) Normalized simultaneously evoked responses recorded from all
cell pairs expressing or nonexpressing Rap2(dn)-GFP against time. h
(C) Steady-state synaptic AMPA-R-mediated response amplitudes o
in paired (n = 10; p < 0.01) and control pathways (n = 10; p = 0.28) n
in cells expressing Rap2(dn)-GFP and neighboring nonexpressing
pcontrol cells before and after pairing.
o(D) Average AMPA-R-mediated synaptic responses obtained be-
Wfore (−60 mV; thick trace) and after (−60 mV; thin trace) LTP-depo-
tentiation-inducing pairing from a pair of Rap2(ca)-GFP-expressing w
and neighboring nonexpressing cells in LTP-depotentiation double a
paired (upper left) and control pathway (upper right). (Lower plot) i
Simultaneously evoked responses recorded from the cell pairs ex-
(pressing or not expressing Rap2(ca)-GFP against time.
(E) Normalized simultaneously evoked responses recorded from
cells expressing or nonexpressing Rap2(ca)-GFP against time.
(F) Steady-state synaptic AMPA-R-mediated response amplitudes
(in paired (n = 9; p = 0.86) and control (n = 9; p = 0.24) pathways
bin cells expressing Rap2(ca)-GFP and neighboring nonexpressing
ccontrol cells before and after pairing. AMPA-R-mediated current
samplitude and standard errors were normalized to average initial
Tvalues from control cells.
0(G) Normalized simultaneously evoked responses recorded from
wcells recorded with or without 5 M SP600125 included in the bath
nsolution, and cells expressing TNIK(dn)-GFP recorded in the normal
Dbath solution against time.R/Q)-GFP alone, suggesting that Rap2(ca)-RFP re-
H) Steady-state synaptic AMPA-R-mediated response amplitudes
efore and after LTP-depotentiation-inducing pairing in cells re-
orded in the normal bath solution (n = 12; p < 0.001) or in the bath
olution with 5 M SP600125 (n = 12; p = 0.54), or cells expressing
NIK(dn)-GFP recorded in the normal bath solution (n = 8; p <
.005). AMPA-R-mediated current amplitude and standard errors
ere normalized to average initial values from cells recorded in the
ormal bath solution. *p < 0.05 (Wilcoxon test). See Supplemental
ata for the values.F). Meanwhile, nearby nonexpressing neurons showed
athway-specific LTP and depotentiation (Figures 5D–
F). These results suggest that constitutively active
ap2 continuously depotentiates synaptic transmis-
ion, which prevents induction of LTP and occludes fur-
her depotentiation. Together, these results indicate
hat Rap2 activity controls depotentiation.
To test whether Rap2 controls depotentiation via
NK, we incubated slices in the bath solution contain-
ng SP600125, an inhibitor of JNK, before (for at least 1
r) and during depotentiation experiments. We found
hat SP600125 blocked depotentiation in CA1 neurons
Figures 5G and 5H). In addition, as with Rap2(dn)-GFP,
xpressing TNIK(dn)-GFP also blocked depotentiation.
ollectively, these results suggest that Rap2 controls
epotentiation via TNIK-JNK signaling.
ap2 Removes Synaptic GluR1- and GluR2L-
ontaining AMPA-Rs
e have previously shown that Rap1 mediates LTD by
emoving synaptic AMPA-Rs with only short cytoplas-
ic termini, such as GluR2/3 (Zhu et al., 2002). Since
ap2 activity controls depotentiation, we asked if Rap2
cts to remove the pool of AMPA-Rs with long cyto-
lasmic termini (e.g., GluR1 and GluR2L), which require
ctivity to be driven into synapses. Previous studies
ave shown that overexpressions of the cytoplasmic
ail constructs of GluR2Lct-GFP and GluR2ct-GFP de-
ress the transmission mediated by AMPA-Rs with
ong and only short cytoplasmic termini, respectively
Kolleker et al., 2003; Shi et al., 2001). We first exam-
ned the effects of coexpression of Rap2(ca)-RFP with
ither GluR2Lct-GFP or GluR2ct-GFP. Coexpression of
ap2(ca)-RFP with GluR2Lct-GFP showed no more
epression than expression of Rap2(ca)-GFP alone,
hile coexpression of Rap2(ca)-RFP with GluR2ct-GFP
howed additive effects (Figures 6A and 6B), indicating
hat Rap2 activity removed AMPA-Rs with long cyto-
lasmic termini, but not GluR2/3 AMPA-Rs. We then di-
ectly examined the effects of Rap2(ca)-RFP on AMPA-
s with only short cytoplasmic termini (Figures 6C and
D). Expressing GluR2(R/Q)-GFP in CA1 neurons en-
anced rectification but had no effect on the amplitude
f AMPA responses in comparison to nearby control
onexpressing neurons (Figures 6C and 6D), due to re-
lacement of synaptic AMPA-Rs with the “electrophysi-
logically tagged” GluR2(R/Q)-GFP (Shi et al., 2001).
e found that neurons coexpressing Rap2(ca)-RFP
ith GluR2(R/Q)-GFP had depressed AMPA-R-medi-
ted transmission and further enhanced rectification
n comparison to neighboring neurons expressing GluR2
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AMPA-Rs
(A) Nonexpressing cells (Ctrl) and cells coexpressing GluR2Lct-
GFP with Rap2(ca)-RFP under transmitted light (top) and fluores-
cence microscopy with either RFP (middle) or GFP (bottom) filter.
(B) (Upper) Evoked AMPA-R-mediated (−60 mV) and NMDA-R-
mediated (+40 mV) responses recorded from nonexpressing cells
(Ctrl) and cells coexpressing GluR2Lct-GFP with Rap2(ca)-RFP.
(Lower left) AMPA responses in cells coexpressing GluR2Lct-GFP
with Rap2(ca)-RFP (n = 14; p < 0.005) or GluR2ct-GFP with
Rap2(ca)-RFP (n = 12; p < 0.005) relative to neighboring nonex-
pressing control cells. (Lower right) NMDA responses in cells ex-
pressing GluR2Lct-GFP with Rap2(ca)-RFP (n = 14; p = 0.36) or
GluR2Lct-GFP with Rap2(ca)-RFP (n = 12; p = 0.06) relative to
neighboring nonexpressing control cells.
(C) Evoked AMPA-R-mediated (−60 mV) responses and rectification
recorded from neighboring cell triples including a nonexpressing
cell (Ctrl), a GluR2(R/Q)-GFP-expressing cell, and a GluR2(R/Q)-
GFP and Rap2(ca)-RFP-coexpressing cell.
(D) (Left) AMPA responses in cells expressing GluR2(R/Q)-GFP
and cells coexpressing GluR2(R/Q)-GFP with Rap2(ca)-RFP (n =
12; p = 0.58 for Ctrl versus exp; p < 0.05 for Ctrl versus co-exp),
cells coexpressing GluR2L(R/Q)-GFP with Rap2(ca)-RFP (n = 14;
p < 0.005), or cells coexpressing GluR1-GFP and Ras(ca)-GFP with
Rap2(ca)-RFP (n = 16; p < 0.01) relative to neighboring nonexpress-
ing control cells. (Right) Rectification of AMPA-R-mediated re-
sponses in cells expressing GluR2(R/Q)-GFP and cells coex-
pressing GluR2(R/Q)-GFP with Rap2(ca)-RFP (n = 12; p < 0.01 for
Ctrl versus exp; p < 0.005 for Ctrl versus co-exp), cells coexpress-
ing GluR2L(R/Q)-GFP with Rap2(ca)-RFP (n = 14; p = 0.64), or
cells coexpressing GluR1-GFP and Ras(ca)-GFP with Rap2(ca)-
RFP (n = 16; p = 0.72) relative to neighboring nonexpressing con-
trol cells.
(E) Evoked AMPA-R-mediated (−60 mV) responses recorded from
neighboring cell triples including a nonexpressing cell (Ctrl) and
two Rap2(ca)-GFP-expressing cells, loading with either G10 or S10.
(F) Normalized simultaneously evoked responses recorded from all
cell triples expressing or nonexpressing Rap2(ca)-GFP against G10
or S10 loading time.
(G) Residual AMPA responses obtained 30 min after loading G10
or S10 from cell triples expressing and nonexpressing Rap2(ca)-
GFP (n = 12; p < 0.005 for Ctrl/G10 versus exp/G10, Ctrl/G10 versus
exp/G10, and exp/G10 versus exp/S10). AMPA-R-mediated current
amplitudes, rectification, and standard errors were normalized to
average values from control cells. *p < 0.05 (Wilcoxon test). See
Supplemental Data for the values.moves AMPA-Rs other than the newly delivered, recti-
fied GluR2(R/Q)-GFP. We also directly examined the
effects of Rap2(ca)-RFP on AMPA-Rs with long cyto-plasmic termini (Figure 6D). Neurons expressing GluR2L
(R/Q)-GFP or neurons coexpressing GluR1-GFP and
Ras(ca)-GFP show enhanced synaptic transmission
and rectification, due to synaptic insertion of “electro-
physiologically tagged” GluR2L(R/Q)-GFP by sponta-
neous synaptic activity (Kolleker et al., 2003; Zhu et al.,
2002), or “electrophysiologically tagged” GluR1-GFP by
constitutively active Ras (Zhu et al., 2002). Neurons
coexpressing Rap2(ca)-RFP with GluR2L(R/Q)-GFP
and neurons coexpressing Rap2(ca)-RFP with GluR1-
GFP and Ras(ca)-GFP showed depressed AMPA-R-
mediated transmission, and the rectification of the re-
sponses was not different from control nonexpressing
neurons, suggesting that Rap2 activity removed the
newly delivered, rectified GluR2L(R/Q)-GFP and GluR1-
GFP. Together, these results indicate that Rap2 activity
removes synaptic AMPA-Rs with long cytoplasmic
termini.
Previous studies have demonstrated that pep2m/
G10 selectively blocks GluR2/3 from cycling back to
synapses (Lee et al., 2002; Luscher et al., 1999; Nishi-
mune et al., 1998; Osten et al., 1998; Song et al., 1998;
Zhu et al., 2000). To further confirm that Rap2 activity
removes synaptic AMPA-Rs with long cytoplasmic ter-
mini, we used an independent experimental approach,
loading CA1 neurons with the peptide pep2m/G10. We
found that intracellular loading of pep2m/G10 de-
pressed AMPA-R-mediated synaptic transmission in
both Rap2(ca)-GFP-expressing cells and neighbor-
ing control nonexpressing cells (Figures 6E–6G). The
depression was significantly larger in Rap2(ca)-GFP-
expressing cells (w85%) than control cells (w50%). As
a control, intracellular loading of S10, an ineffective
peptide with a scrambled amino acid order, had no ef-
fect on synaptic transmission in neighboring Rap2(ca)-
GFP-expressing cells (Figures 6E–6G). Collectively,
these results indicate that Rap2 activity removes syn-
aptic AMPA-Rs with long cytoplasmic termini but not
those with only short cytoplasmic termini.
Previous studies have shown that dephosphorylation
of AMPA-Rs with long cytoplasmic termini correlates
with the synaptic removal of these receptors during
synaptic depression (Song and Huganir, 2002). We first
examined the levels of phosphorylated GluR2L at S841,
the site homologous to GluR1 at S845 (Song and
Huganir, 2002), in extracts from slices expressing
Rap2(ca)-GFP or Rap2(dn)-GFP. Western blot analysis
showed that CA1 cells expressing Rap2(ca)-GFP had
decreased phosphorylation of GluR2L at S841, whereas
CA1 cells expressing Rap2(dn)-GFP had increased phos-
phorylation of GluR2L at S841 (Figure 7A). However,
CA1 cells expressing Rap2(ca)-GFP or Rap2(dn)-GFP
had no significant change in phosphorylation of GluR1
at S831 and S845 (Figure 7B). Given that Rap2-JNK sig-
naling pathway controls depotentiation, which occurs
only in recently potentiated synapses (Bear and Linden,
2000; Zhou and Poo, 2004), it is possible that this sig-
naling pathway dephosphorylates only newly delivered
AMPA-Rs. Because LTP-inducing stimuli or constitu-
tively active Ras, but not spontaneous activity, drives
synaptic delivery of GluR1 in vitro (Shi et al., 2001; Za-
manillo et al., 1999; Zhu et al., 2002), we examined the
effects of Rap2(ca)-RFP or Rap2(dn)-RFP on GluR1 in
CA1 cells that coexpress active Ras(ca)-GFP, which
Neuron
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ylation of GluR1 and GluR2L Receptors
(A) (Left) Western blots of phospho-p841-
GluR2L in control hippocampal CA1 regions
and hippocampal CA1 regions expressing
Rap2(ca)-GFP and Rap2(dn)-GFP. Each lane
was loaded with the same amount of protein
(40 g). (Right) Relative amounts of phos-
pho-p841-GluR2L in hippocampal CA1 re-
gions expressing Rap2(ca)-GFP (n = 17; p <
0.005) or Rap2(dn)-GFP (n = 17; p < 0.01).
Relative amounts of total GluR2L in hippo-
campal CA1 regions expressing Rap2(ca)-
GFP (n = 17; p = 0.74) or Rap2(dn)-GFP (n =
17; p = 0.44).
(B) (Upper left) Western blots of phospho-
p831-GluR1 in control hippocampal CA1 re-
gions and hippocampal CA1 regions ex-
pressing Rap2(ca)-GFP and Rap2(dn)-GFP.
Each lane was loaded with the same amount
of protein (30 g). (Upper right) Relative
amounts of phospho-p831-GluR1 in hippo-
campal CA1 regions expressing Rap2(ca)-
GFP (n = 16; p = 0.13) or Rap2(dn)-GFP(n =
16; p = 0.33). Relative amounts of total GluR1
in hippocampal CA1 regions expressing
Rap2(ca)-GFP (n = 16; p = 0.11) or Rap2(dn)-
GFP (n = 16; p = 0.15). (Lower left) Western
blots of phospho-p845-GluR1 in control hippocampal CA1 regions and hippocampal CA1 regions expressing Rap2(ca)-GFP and Rap2(dn)-
GFP. Each lane was loaded with the same amount of protein (40 g). (Lower right) Relative amounts of phospho-p845-GluR1 in hippocampal
CA1 regions expressing Rap2(ca)-GFP (n = 16; p = 0.87) or Rap2(dn)-GFP(n = 16; p = 0.39). Relative amounts of total GluR1 in hippocampal
CA1 regions expressing Rap2(ca)-GFP (n = 16; p = 0.99) or Rap2(dn)-GFP (n = 16; p = 0.54). The relative values and standard errors were
normalized to average amounts of phospho-p831-GluR1 and phospho-p845-GluR1 or total GluR1 from control hippocampal CA1 regions.
(C) (Upper left) Western blots of phospho-p831-GluR1 in hippocampal CA1 regions expressing Ras(ca)-GFP, Ras(ca)-GFP-IRES-Rap2(ca)-
RFP, and Ras(ca)-GFP-IRES-Rap2(dn)-RFP. Each lane was loaded with the same amount of protein (30 g). (Upper right) Relative amounts of
phospho-p831-GluR1 in hippocampal CA1 regions expressing Ras(ca)-GFP-IRES-Rap2(ca)-RFP (n = 13; p < 0.01) or Ras(ca)-GFP-IRES-
Rap2(dn)-RFP (n = 13; p < 0.01) to neurons expressing Ras(ca)-GFP. Relative amounts of total GluR1 in hippocampal CA1 regions expressing
Ras(ca)-GFP-IRES-Rap2(ca)-RFP (n = 13; p = 0.42) or Ras(ca)-GFP-IRES-Rap2(dn)-RFP (n = 13; p = 0.86) to neurons expressing Ras(ca)-GFP.
(Lower left) Western blots of phospho-p845-GluR1 in control hippocampal CA1 regions expressing Ras(ca)-GFP, Ras(ca)-GFP-IRES-Rap2(ca)-
RFP, and Ras(ca)-GFP-IRES-Rap2(dn)-RFP. Each lane was loaded with the same amount of protein (40 g). (Lower right) Relative amounts of
phospho-p845-GluR1 in hippocampal CA1 regions expressing Ras(ca)-GFP-IRES-Rap2(ca)-RFP (n = 15; p < 0.05) or Ras(ca)-GFP-IRES-
Rap2(dn)-RFP (n = 15; p < 0.01) to neurons expressing Ras(ca)-GFP. Relative amounts of total GluR1 in hippocampal CA1 regions expressing
Ras(ca)-GFP-IRES-Rap2(ca)-RFP (n = 15; p = 0.87) or Ras(ca)-GFP-IRES-Rap2(dn)-RFP (n = 15; p = 0.65) to neurons expressing Ras(ca)-GFP.
The relative values and standard errors were normalized to average amounts of phospho-p831-GluR1 and phospho-p845-GluR1 or total
GluR1 from control hippocampal CA1 regions expressing Ras(ca)-GFP. *p < 0.05 (Wilcoxon test). See Supplemental Data for the values.drives synaptic delivery of GluR1 (Zhu et al., 2002).
Western blot analysis showed that, in comparison to f
CA1 cells expressing Ras(ca)-GFP, CA1 cells express- s
ing Ras(ca)-GFP-IRES-Rap2(ca)-RFP had decreased a
phosphorylation of GluR1 at S831 and S845, while CA1 a
cells expressing Ras(ca)-GFP-IRES-Rap2(dn)-RFP had s
increased phosphorylation of GluR1 at S831 and S845 b
(Figure 7C). These results together suggest that Rap2- e
JNK signaling dephosphorylates AMPA-Rs with long R
cytoplasmic termini. G
G
cDiscussion
d
hIn this study, we provide evidence that Rap2 activity
wstimulates JNK signaling in hippocampal cells. More
limportantly, our results indicate that Rap2-JNK consti-
Wtutes a functional signaling pathway that regulates ex-
ccitatory synapses. This pathway receives inputs from
mNR2A-containing NMDA-Rs during synaptic activation
pand sends outputs that result in synaptic removal of
pAMPA-Rs with long cytoplasmic termini during synaptic
depotentiation (Figure 8). AA number of studies indicate that the regulated traf-
icking of postsynaptic AMPA-Rs controls synaptic
trength and plasticity at excitatory synapses (Bredt
nd Nicoll, 2003; Malinow and Malenka, 2002; Sheng
nd Kim, 2002; Song and Huganir, 2002). Four major
ynaptic AMPA-R trafficking processes have so far
een identified: first, activity-dependent synaptic deliv-
ry of GluR1-, GluR2L-, and GluR4-containing AMPA-
s; second, activity-independent synaptic exchange of
luR1-, GluR2L-, or GluR4-containing AMPA-Rs with
luR2/3 AMPA-Rs; third, activity-independent synaptic
ycling of GluR2/3 AMPA-Rs; and fourth, activity-
ependent synaptic removal of GluR2/3 AMPA-Rs. We
ave recently shown that Ras and Rap1 signaling path-
ays control activity-dependent synaptic AMPA-R de-
ivery and removal, respectively (Zhu et al., 2002).
hether activity-independent synaptic AMPA-R ex-
hange and synaptic AMPA-R cycling are regulated re-
ains unclear. What is missing from this trafficking
icture is synaptic removal of AMPA-Rs with long cyto-
lasmic termini (e.g., GluR1- and GluR2L-containing
MPA-Rs); the obvious questions are how AMPA-Rs
Rap2-JNK Signaling and Depotentiation
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Pathway-Mediated Synaptic Plasticitywith long cytoplasmic termini are removed from syn-
apses after delivery and whether the removal is regu-
lated. Here, we report the fifth AMPA-R trafficking pro-
cess at synapses: synaptic removal of GluR1- and
GluR2L-containing AMPA-Rs that underlies depotentia-
tion (Figure 8). This process is activity dependent and
controlled by a Rap2-JNK signaling pathway, which
consists of several molecule members, including NR2A-
containing NMDA-Rs as signaling input receivers, TNIK
and PP2B as potential signaling intermediate relays,
and GluR1- and GluR2L-containing AMPA-Rs as signal-
ing output targets.
Rap2 was cloned at the same time as Rap1; both Rap
proteins were speculated to antagonize proneoplastic
functions of Ras (Pizon et al., 1988). However, the exact
function of Rap2 remains elusive due in part to lack of
understanding of how Rap2 is activated in nonneuronal
or neuronal cells. In the present study, we report that
activation of NMDA-Rs stimulates Rap2 signaling that in
turn controls depotentiation. We further show that ac-
tivity of Rap2 requires activation of NR2A-containing
NMDA-Rs. Together, our results suggest that NR2A-
containing NMDA-Rs serve as signaling input receptors
for Rap2-JNK pathway at synapses (Figure 8).
Although Rap2 activity mediates signaling from syn-
aptic activation of NR2A-containing NMDA-Rs, and it
removes AMPA-Rs during depotentiation, additional
molecules are likely to exist in the Rap2 pathway to
serve the relays (e.g., mediating the activation from
Rap2 to JNK) and functions (e.g., dephosphorylating
AMPA-Rs). Already, a few additional molecules have
been implicated for these roles by previous and our
studies. For example, Rap2 seems to bind selectively
to TNIK and MINK2, which have been shown to be spe-
cific upstream effectors of the JNK pathway (Dan et al.,
2001). In addition, blocking endogenous TNIK activity
potentiates synaptic transmission and blocks depoten-
tiation and the Rap2(ca)-GFP-stimulated depression
(Figure 3). Moreover, the depressive effect of Rap2 is
dependent on activation of phosphatase 2B, which is
known to be important for depotentiation (Malleret et
al., 2001; Zhuo et al., 1999). A full investigation of thefunctional roles of TNIK/MINK2 and phosphatase 2B in
Rap2-JNK signaling pathway should address whether
TNIK and MINK2 relay the signaling from Rap2 to JNK
during synaptic depression and whether phosphatase
2B responds to Rap2-JNK signaling and dephosphory-
lates AMAP-Rs during depotentiation.
We reveal in this study that Rap2 removes synaptic
AMPA-Rs with long cytoplasmic termini during depo-
tentiation (Figure 8). In particular, Rap2-JNK signaling
stimulates synaptic removal of GluR2L- and GluR1-
containing AMPA-Rs and dephosphorylation of GluR2L
at S841 and GluR1 at S831 and S845. These results are
largely congruent with previous findings that dephos-
phorylation of AMPA-Rs with long cytoplasmic termini
correlates with synaptic depression (Song and Huganir,
2002). We noted that one of our observations is at odds
with a previous study, which reported that depotentia-
tion was accompanied by dephosphorylation of GluR1
at only S845 (Lee et al., 2000). The discrepancy may be
explained by a number of differences between our
study and the previous report. For example, changes
of phosphorylation of GluR1 are dependent on both the
basal phosphorylation level of the receptor (presumably
regulated by spontaneous synaptic activity) and activ-
ity patterns (Blackstone et al., 1994; Mammen et al.,
1997). In our study, culture slices, in which spontaneous
synaptic activity is largely preserved (Zhu et al., 2000),
were used, and most synapses of almost all CA1 neu-
rons were affected by expression of recombinant Rap2
proteins. In contrast, the previous study examined a
small number of synapses of CA1 neurons activated
by electric stimuli in acute slices. Consistent with our
observation, a recent study reported that the Rab5-
driven synaptic removal of GluR1 is accompanied by
dephosphorylation of GluR1 at both S831 and S845 in
CA1 neurons (Brown et al., 2005). Further experiments
are needed to determine whether the differences in ex-
perimental conditions, as well as other factors (e.g.,
sensitivity of anti-phospho-GluR1 antibodies), may un-
derlie the difference between these observations.
Whether MAPK pathways cross talk is somewhat
controversial. Recent evidence suggests that MAPK
pathways may function independently in subcellular
compartments in nonneuronal cells (Enserink et al.,
2002; Mochizuki et al., 2001; Xia et al., 1995). Consis-
tent with this idea, we have previously found that Ras-
Erk1/2 and Rap1-p38 MAPK pathways independently
signal synaptic delivery of GluR1- and GluR2L-contain-
ing AMPA-Rs during LTP and synaptic removal of
GluR2/3 AMPA-Rs during LTD in CA1 neurons, respec-
tively (Zhu et al., 2002). Here, we further show that
Rap2-JNK controls synaptic removal of AMPA-Rs with
long cytoplasmic termini (i.e., GluR1 and GluR2L) dur-
ing depotentiation. Our results also suggest that activa-
tion of NR2A-containing NMDA-Rs stimulates Rap2-
JNK and Ras-Erk1/2 signaling, while activation of NR2B-
containing NMDA-Rs stimulates Rap1-p38 MAPK sig-
naling. These results are consistent with recent findings
that depotentiation/LTP and LTD require activation of
NR2A- and NR2B-containing NMDA-Rs, respectively (Liu
et al., 2004; Massey et al., 2004). Since the signaling in-
put receptors, molecular links, targets of signaling, and
functional effects are different, our data suggest that
three major MAPK signaling pathways, Rap2-JNK,
Neuron
914TRap1-p38 MAPK, and Ras-Erk1/2, serve as indepen-
Gdent signaling pathways (Figure 8).
bThe most extensively studied examples of synaptic
d
plasticity are NMDA-R-dependent LTP, LTD, and depo- C
tentiation. Our results, together with several recent (
Rfindings, are now impelling an intriguing notion that in-
Rdependent molecular and cellular processes control
sdistinct forms of synaptic plasticity (Figure 8). In partic-
Gular, these results indicate that depotentiation, LTP, and
c
LTD are triggered by activation of different NMDA-Rs 2
(Liu et al., 2004; Massey et al., 2004), mediated by sep- i
tarate MAPK signaling pathways and distinct aspects of
oAMPA-R trafficking (Zhu et al., 2000; and this study),
6and they employ special pools of endosomes (Brown
1et al., 2005; Ehlers, 2000; Lee et al., 2004; Luscher et
c
al., 1999; Park et al., 2004). Obvious puzzles that still i
remain are how these three MAPK signaling pathways b
rare linked to different NMDA-R subunits, and how they
oregulate cycling of distinct endosomes. Functional
wcharacterization of the guanine nucleotide exchange
mfactors and GTPase activating proteins for Ras and
c
Rap, a variety of which are prominent at excitatory syn- a
apses (Husi et al., 2000; Pak et al., 2001; Peng et al., f
2004), as well as examination of the effects of Ras and
Rap on cycling of endosomes, should provide useful E
answers to these important questions. S
t
Experimental Procedures t
c
Biochemical Analyses Z
Hippocampal extracts were prepared by homogenizing hippocam- A
pal CA1 regions isolated from cultured slices (Zhu et al., 2000; Zhu F
et al., 2002), or hippocampal culture cells (Pak et al., 2001). Viral s
expression efficacy of recombinant proteins in these experiments C
was high (>95% of CA1 neurons). Homogenizing solution contained c
the following: 10 mM HEPES, 150 mM NaCl, 10 mM EDTA, 4 mM 2
EGTA, 0.2 mM PMSF, 0.1 mM NaPPi, 0.5 mM NaF, 1 mM Na3VO4, 2
0.0001% Chymostatin, 0.0001% Leupeptin, 0.0001% Antipain, m
0.0001% Pepstatin, and 1% Triton. Membranes were blotted with A
anti-phospho-JNK (1:2000; Cell Signaling Technology, Beverly, MA), S
anti-phospho-Erk1/2 (1:10000; Cell Signaling), anti-phospho-p38 t
MAPK antibody (1:2000; Cell Signaling), anti-phospho-p841- c
GluR2L (gift from Dr. R. Malinow), anti-phospho-p845-GluR1 (1:800; M
Chemicon, Temecula, CA), or anti-phospho-p831-GluR1 (1:1000; w
Chemicon), stripped, and reblotted with anti-JNK (1:2000; Cell Sig- s
naling), anti-Erk1/2 (1:2000; Cell Signaling), anti-p38 MAPK anti- t
body (1:1000; Cell Signaling), anti-GluR2L (Kolleker et al., 2003), or C
anti-GluR1 (1:8000; Chemicon). Active Rap2 was detected by affin- N
ity precipitation of Rap2-GTP with GST-linked Rap binding domain m
of Raf-1 or RalGDS (GST-RBD) as described in a previous report i
(de Rooij et al., 1999). The bound Rap2-GTP was then eluted and e
Western blotted with anti-Rap2 antibodies (1:1000, Santa Cruz Bio- s
technology, Santa Cruz, CA; or 1:2500, Transduction Laboratories, l
Lexington, KY). Rap effectors were purified by incubating GST- r
Rap1(V12), GST-Rap2(V12) (gifts of Dr. J. de Gunzburg), or GST a
alone with membrane extracts (crude synaptosomes from 40 adult w
rat brains solubilized in 1% Triton X-100). Bound material was w
washed, concentrated, extracted, and then separated by SDS- −
PAGE. A 150 kDa band specifically associated with active Rap2 w
was excised and subjected to microcapillary LC/MS/MS tandem A
mass spectrometry for protein identification. Western blots were s
quantified by chemiluminescence and densitometric scanning of m
the films under linear exposure conditions. a
D
1Constructs of Recombinant Proteins and Expression
Rap2 mutant constructs, including the constitutively active mutant S
a(G12/E), dominant-negative mutant (S17/N), and null/dead mu-
tant (F39/S; Machida et al., 2004), were generated using Quick 1
(Change Site-Directed mutagenesis kit (Stratagene, La Jolla, CA).hese mutants were then subcloned into pEGFP-C1 (enhanced
FP, Clontech Laboratories, Palo Alto, CA) or pRFP-C1 (generated
y replacing EGFP in pEGFP-C1 with dsRed-MST-B). GFP-tagged
ominant-negative TNIK, TNIK(dn)-GFP, was made by ligating the
-terminal regulatory domain of TNIK sequence into pEGFP-C1
Taira et al., 2004). To coexpress Ras(ca)-GFP with Rap2(ca)-RFP or
ap2(dn)-RFP virally, Ras(ca)-GFP and Rap2(ca)-RFP or Rap2(dn)-
FP were subcloned before and after an internal ribosomal entry
ite (IRES) sequence (from pCITE-GFP) to produce Ras(ca)-
FP-IRES-Rap2(ca)-RFP or Ras(ca)-GFP-IRES-Rap2(dn)-RFP. Other
onstructs were made as previously described (Kolleker et al.,
003; Zhu et al., 2000; Zhu et al., 2002). Constructs were expressed
n CA1 neurons in hippocampal slices using Sindbis virus or biolis-
ics transfection. Slices were prepared from postnatal 6- to 7-day-
ld rats, infected with virus or transfected using gene gun after
–8 days in vitro, and incubated on culture media and 5% CO2 for
4 ± 2 hr before experiments. By monitoring GFP or RFP fluores-
ence, we observed that recombinant Rap2 proteins first appeared
n CA1 neurons after w6–8 hr of infection or transfection. Western
lot analysis showed that recombinant Rap2 expression level
eached w2 to 8 times the endogenous Rap2 level after 14 ± 2 hr
f infection or transfection (see Figure 1A). Thus, all experiments
ere performed within 14 ± 2 hr after infection or transfection to
inimize activation of multiple or nonspecific pathways due to ex-
essive overexpression of recombinant proteins and/or prolonged
ctivation of Rap2 signaling pathway (e.g., autocrine/paracrine ef-
ects; see McCarthy et al., 1995).
lectrophysiology
imultaneous whole-cell recordings were obtained from pairs or
riples of neighboring infected/transfected and noninfected/non-
ransfected CA1 neurons, under visual guidance using fluores-
ence and transmitted light illumination (Larkum and Zhu, 2002;
hu et al., 2000). Synaptic currents were recorded using up to three
xopatch-200B and/or Axoclamp-1D amplifiers (Axon Instruments,
oster City, CA). Bath solution (29°C ± 1.5°C), unless otherwise
tated, contained the following: 119 mM NaCl, 2.5 mM KCl, 4 mM
aCl2, 4 mM MgCl2, 26 mM NaHCO3, 1 mM NaH2PO4, 11 mM glu-
ose, 0.1 mM picrotoxin, 0.01 mM bicuculline, and 0.002 mM
-chloroadenosine (pH 7.4 and gassed with 5% CO2/95% O2).
-chloroadenosine was included to prevent bursting. For experi-
ents in which slices were maintained in culture with cyclosporin
, FK-506, PD98059, SB203580 (Calbiochem, La Jolla, CA), or
P600125 (gift from Signal Pharmaceutical Inc, San Diego, CA),
hese drugs were included during recordings. NR2A- and NR2B-
ontaining NMDA-R inhibitors Ro25-6981 (Sigma-Aldrich, St. Louis,
O) and NVP-AAM077 (Novartis Pharma AG, Basel, Switzerland),
hich were included in culture media, were not included in the bath
olution during recordings. Patch recording pipettes (3–6 M) con-
ained the following: 115 mM cesium methanesulfonate, 20 mM
sCl, 10 mM HEPES, 2.5 mM MgCl2, 4 mM Na2ATP, 0.4 mM
a3GTP, 10 mM sodium phosphocreatine, 0.6 mM EGTA, and 0.1
M spermine (pH 7.25). The access resistance (10–25 M) and
nput resistance (300–500 M) were continuously monitored during
xperiments and varied less than 20% during any experimental
eries. Occasionally, recordings had higher access resistance or
ower input resistance, or displayed changes in access and input
esistance more than 20%; these recordings were not included in
nalysis. Synaptic responses were evoked by bipolar electrodes
ith single voltage pulses (200 s, up to 20 V) placed in s. radiatum
300–500 m from the CA1 cells. Synaptic AMPA responses at
60 mV and +40 mV were averaged over 90 trials, and their ratio
as used as an index of rectification. To minimize the effect from
MPA responses, the peak NMDA responses at +40 mV were mea-
ured after digital subtraction of estimated AMPA responses at +40
V. LTP was induced by a pairing protocol using 200 pulses at 2 Hz
t −5 mV within 5 min after formation of whole-cell configuration.
epotentiation is induced by a pairing protocol using 300 pulses at
Hz at −45 mV 30 min after induction of LTP in the presence of
B203580, which blocks LTD (Zhu et al., 2002). SB203580 (2 M)
nd SP600125 (5 M) were incubated in solution before (for at least
hr) and during depotentiation experiments. Peptides pep2m/G10
KRMKVAKNAQ) and S10 (VRKKNMAKQA) (GenScript Corporation,
Rap2-JNK Signaling and Depotentiation
915Scotch Plains, NJ) were dissolved (1 mM) in Cs-based internal solu-
tion. All results are reported as mean ± SEM, and statistical differ-
ences of the means were determined using Wilcoxon nonparamet-
ric test unless otherwise stated. Significance was set at p < 0.05.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/46/6/905/DC1/.
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